Search by Drug Name or NDC
NDC 58809-0189-08 VANACOF CP Allergy / Cough 12.5; 25 mg/15mL; mg/15mL Details
VANACOF CP Allergy / Cough 12.5; 25 mg/15mL; mg/15mL
VANACOF CP Allergy / Cough is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by GM Pharmaceuticals, INC. The primary component is CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE.
Product Information
| NDC | 58809-0189 |
|---|---|
| Product ID | 58809-189_0c7c6099-e68f-89e9-e063-6394a90a2b7d |
| Associated GPIs | |
| GCN Sequence Number | 085623 |
| GCN Sequence Number Description | pyrilamine/chlophedianol LIQUID 25-12.5/15 ORAL |
| HIC3 | B4E |
| HIC3 Description | NON-OPIOID ANTITUSSIVE-1ST GEN ANTIHISTAMINE COMB. |
| GCN | 55139 |
| HICL Sequence Number | 040404 |
| HICL Sequence Number Description | PYRILAMINE MALEATE/CHLOPHEDIANOL HCL |
| Brand/Generic | Brand |
| Proprietary Name | VANACOF CP Allergy / Cough |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Chlophedianol HCl, Pyrilamine Maleate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 12.5; 25 |
| Active Ingredient Units | mg/15mL; mg/15mL |
| Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; PYRILAMINE MALEATE |
| Labeler Name | GM Pharmaceuticals, INC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M012 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 58809-0189-08 (58809018908)
| NDC Package Code | 58809-189-08 |
|---|---|
| Billing NDC | 58809018908 |
| Package | 1 mL in 1 BOTTLE (58809-189-08) |
| Marketing Start Date | 2023-12-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |